Investors Snag CASI 24.4% Lower Than Its Secondary Stock OfferingBy Market News Video Staff, Thursday, June 24, 11:10 AM ETLooking back to 92 days ago, CASI Pharmaceuticals, Inc. (NASDAQ:CASI) priced a 15,853,658 share secondary stock offering at $2.05 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time. In trading on Thursday, bargain hunters could buy shares of CASI and achieve a cost basis 24.4% cheaper than those buyers, with shares changing hands as low as $1.55 per share. Secondaries can often present buying opportunities for bullish investors interested in purchasing shares, because the sudden extra supply of stock tends to require that the offering be priced at an attractive discount to where the stock had previously been trading before the offering announcement. At last check, CASI Pharmaceuticals, Inc. shares are currently trading down about 0.9% on the day. The chart below shows the one year performance of CASI shares, versus its 200 day moving average:
Looking at the chart above, CASI's low point in its 52 week range is $1.32 per share, with $3.90 as the 52 week high point — that compares with a last trade of $1.56. Special Offer: Receive our best dividend ideas directly to your inbox each afternoon with the Dividend Channel Premium Newsletter
This Article's Word Cloud:
Buyers
CASI
Channel
Dividend
Looking
Newsletter
Offer
Offerings
Pharmaceuticals
Premium
Receive
Recent
Secondaries
Secondary
Special
Start
Stock
Thursday
about
above
achieve
afternoon
announcement
attractive
average
back
bargain
basis
because
been
before
below
best
bullish
buyers
buying
changing
chart
investment
last
offering
point
priced
share
shares
stock
that
trading
week
with
|